- Amphibians can learn to avoid infectious
fungi, can acquire resistance after repeated exposures, and can be
immunised with dead fungi, a study in Nature reports.
- Nature Conferences - Immune Homeostasis and Inflammatory Disease: A Herrenhausen Symposium.
- The latest Nature Podcast on SoundCloud: The
STAP cell paper retractions, immunising frogs against a deadly fungus,
how kangaroos use their tails as a fifth leg - and how scientists change
the optical properties of a material by applying electricity.
- Publishing is one of the most ballyhooed
metrics of scientific careers. Now, a new study finds that very few
scientists—fewer than 1%—manage to publish a paper every year. But this
1% of scientists dominates the research journals, having their names on
41% of all papers (and on 87% of the most highly cited.)
- Insight: Hepatitis C can be cured globally, but at what cost?
The high costs of drugs for treating Hepatitis
C, which kills up to 500,000 people every year -- more than
tuberculosis or malaria -- can be significantly
decreased with the mass production of generic versions, according to
the authors of a Perspective in this week’s issue. New drugs capable of
curing 90 percent of patients cost between $60,000 to $85,000 per person
for a 12 weeks of treatment. With generics, these costs can be brought
down to somewhere between $75 and $170 for the same time span. But
current U.S. patents prohibit companies from producing generic versions
of the drugs for the next 12 to 15 years.
No hay comentarios:
Publicar un comentario